Omega-3 Fatty Acids Enriched Food and Microvascular Reactivity
NCT ID: NCT02720250
Last Updated: 2016-03-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
50 participants
INTERVENTIONAL
2016-03-31
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
However, there is a lack of studies showing the effect of everyday consumption of omega-3 fatty acids enriched food (not pills) on lipid profile and microvascular reactivity in healthy population.
This study aimed to determine the effect of omega-3 enriched chicken eggs consumption on microvascular reactivity and lipid profile in young healthy subjects.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
N-3 Polyunsaturated Fatty Acids Enriched Chicken Meet and Cardiovascular Function
NCT05725486
Impacts of Omega-3-PUFA Enriched Chicken-meat and Eggs in Healthy Humans
NCT04127409
Cardiometabolic Benefits of Omega-3 Polyunsaturated Fatty Acids
NCT03378232
Efficacy Study Regarding the Beneficial Effects of Omega-3 Fatty Acids on Cardiometabolic Health
NCT02042274
Omega-3-Index Response to Eating Poultry Foods Naturally Enriched With Omega-3 Polyunsaturated Fatty Acids
NCT06259825
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Omega-3
Intake of 3 omega-3 fatty acids enriched chicken eggs per day for three weeks.
Omega-3 chicken eggs
Intake of 3 omega-3 fatty acids enriched chicken eggs per day for three weeks.
Regular
Intake of 3 regular chicken eggs per day for three weeks.
Regular chicken eggs
Intake of 3 regular chicken eggs per day for three weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Omega-3 chicken eggs
Intake of 3 omega-3 fatty acids enriched chicken eggs per day for three weeks.
Regular chicken eggs
Intake of 3 regular chicken eggs per day for three weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* drugs that could affect endothelium
* hypertension
* coronary artery disease
* diabetes
* hyperlipidaemia
* renal impairment
* cerebrovascular and peripheral artery disease
18 Years
35 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Josip Juraj Strossmayer University of Osijek
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ines Drenjancevic
Vice Dean for Science, Faculty of Medicine Josip Juraj Strossmayer University of Osijek
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ines Drenjancevic, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Faculty of Medicine, University of Osijek, Croatia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Medicine Osijek, Laboratory for Clinical and Sport Physiology
Osijek, , Croatia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Cavka A, Cosic A, Jukic I, Jelakovic B, Lombard JH, Phillips SA, Seric V, Mihaljevic I, Drenjancevic I. The role of cyclo-oxygenase-1 in high-salt diet-induced microvascular dysfunction in humans. J Physiol. 2015 Dec 15;593(24):5313-24. doi: 10.1113/JP271631. Epub 2015 Dec 7.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2158610714114
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.